D
Patient 1
THE CUSTOMER RECEIVED QUESTIONABLE IGG ANTIBODIES TO TOXOPLASMA GONDII (TOXO IGG) RESULTS ON THEIR E601 ANALYZER. THE PATIENT WAS BEING MONITORED MONTHLY DURING HER PREGNANCY FOR TOXO IGG USING A VIDAS ANALYZER WITH NEGATIVE RESULTS,
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | COBAS 6000 E601 MODULE | IMMUNOCHEMISTRY ANALYZER | ROCHE DIAGNOSTICS | LJK | NA | 04745922001 | NA | R | Y |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2011-10-04 | 0 |
Patient 1
THE CUSTOMER RECEIVED QUESTIONABLE IGG ANTIBODIES TO TOXOPLASMA GONDII (TOXO IGG) RESULTS ON THEIR E601 ANALYZER. THE PATIENT WAS BEING MONITORED MONTHLY DURING HER PREGNANCY FOR TOXO IGG USING A VIDAS ANALYZER WITH NEGATIVE RESULTS,
Patient 1
IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA. THE EVENT OCCURRED IN (B)(6).
Patient 1
THE PATIENT HAD NEGATIVE TOXO IGG RESULTS ON A VIDAS ANALYZER FOR THE PREVIOUS EIGHT MONTHS.
Patient 1
THE PATIENT SAMPLE WAS RETURNED FOR INVESTIGATION. REACTIVE/POSITIVE RESULTS WERE OBTAINED. THE POSITIVE TOTO IGG RESULT IS REGARDED AS CORRECTLY POSITIVE. THE PATIENT WAS NOT HARMED.